PetMed Express (PETS) to Release Earnings on Monday
PetMed Express (NASDAQ:PETS) is scheduled to be issuing its quarterly earnings data on Monday, January 22nd. Analysts expect the company to announce earnings of $0.31 per share for the quarter.
PetMed Express (NASDAQ:PETS) last announced its quarterly earnings results on Monday, October 23rd. The company reported $0.43 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.30 by $0.13. PetMed Express had a net margin of 11.58% and a return on equity of 31.46%. The firm had revenue of $66.70 million for the quarter, compared to analyst estimates of $63.41 million. During the same period last year, the business earned $0.24 EPS. PetMed Express’s revenue for the quarter was up 9.7% compared to the same quarter last year. On average, analysts expect PetMed Express to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Shares of PetMed Express (NASDAQ PETS) opened at $53.24 on Friday. PetMed Express has a one year low of $19.21 and a one year high of $53.90. The company has a market cap of $1,100.00, a price-to-earnings ratio of 35.73, a P/E/G ratio of 3.02 and a beta of 1.12.
PETS has been the topic of several research analyst reports. Zacks Investment Research lowered shares of PetMed Express from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 25th. BidaskClub upgraded shares of PetMed Express from a “buy” rating to a “strong-buy” rating in a research note on Saturday, December 9th. Northcoast Research set a $58.00 price target on shares of PetMed Express and gave the stock a “buy” rating in a research note on Wednesday, January 3rd. ValuEngine lowered shares of PetMed Express from a “buy” rating to a “hold” rating in a research note on Monday, October 2nd. Finally, Noble Financial reiterated a “hold” rating on shares of PetMed Express in a research note on Friday, October 27th. One analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the stock. PetMed Express has an average rating of “Hold” and a consensus price target of $42.80.
PetMed Express Company Profile
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.